Product Information
Canagliflozin D4 is a synthetic compound that inhibits the SGLT2 transporter and increases the renal excretion of glucose. Canagliflozin D4 is used in the treatment of type 2 diabetes mellitus and is marketed as Invokana. Canagliflozin D4 is a racemic mixture of two enantiomers, with (S)-canagliflozin being more potent than (R)-canagliflozin. The reaction monitoring technique was used to monitor the production of metformin from canagliflozin D4 by extraction with diethyl ether. A validated method for quantification and monitoring was developed using deuterated water for flow rate linearity optimization. This method was applied to plasma samples obtained from healthy Indian subjects who were administered canagliflozin D4 at variable doses over 24 hours. The pharmacokinetic parameters were determined for each subject, resulting in an optimization of this drug dose range.
Chemical properties
Technical inquiry about: 3D-FC146109 Canagliflozin D4
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
